Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2361]

Triple negative breast cancer: OlympiA study

Dr Zeina Nahleh - Cleveland Clinic Weston, Florida, USA

Triple negative breast cancer: OlympiA study ( Dr Zeina Nahleh - Cleveland Clinic Weston, Florida, USA )

Pancreatic and Hepatobiliary Cancers

Dr Caio Max Rocha Lima - Wake Forest Baptist Health, North Carolina, USA

Pancreatic and Hepatobiliary Cancers ( Dr Caio Max Rocha Lima - Wake Forest Baptist Health, North Carolina, USA )

Immunotherapy in lung cancer

Dr Luis Raez - Memorial Healthcare System, Hollywood, Florida, USA

Immunotherapy in lung cancer ( Dr Luis Raez - Memorial Healthcare System, Hollywood, Florida, USA )

Oesophageal and gastric cancers

Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA

Oesophageal and gastric cancers ( Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA )

BEACON-CRC: first-line bevacizumab in colorectal cancer treatment

Prof Dan Aderka - Tel-Aviv University, Tel-Aviv, Israel

BEACON-CRC: first-line bevacizumab in colorectal cancer treatment ( Prof Dan Aderka - Tel-Aviv University, Tel-Aviv, Israel )

Patterns of recurrence after a radical nephroureterectomy in high-risk upper...

Dr Alberto Martini - Vita-Salute San Raffaele University, Milan, Italy

Patterns of recurrence after a radical nephroureterectomy in high-risk upper tract urothelial carcinoma ( Dr Alberto Martini - Vita-Salute San Raffaele University, Milan, Italy )

Part 1: When to test

PARP inhibition in the treatment of prostate cancer

Part 1: When to test ( PARP inhibition in the treatment of prostate cancer )

Part 2: Who to test

PARP inhibition in the treatment of prostate cancer

Part 2: Who to test ( PARP inhibition in the treatment of prostate cancer )

Part 3: How to test

PARP inhibition in the treatment of prostate cancer

Part 3: How to test ( PARP inhibition in the treatment of prostate cancer )

Part 4: Metastatic prostate cancer and HRR defects

PARP inhibition in the treatment of prostate cancer

Part 4: Metastatic prostate cancer and HRR defects ( PARP inhibition in the treatment of prostate cancer )

Part 5: BRCA 1/2 mutations and prostate cancer

PARP inhibition in the treatment of prostate cancer

Part 5: BRCA 1/2 mutations and prostate cancer ( PARP inhibition in the treatment of prostate cancer )

The role of testing in prostate cancer treatment

Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki

The role of testing in prostate cancer treatment ( Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki )

More from ecancer